Search Results - "Bonifati, C"
-
1
Nail psoriasis: a rare mRNA COVID‐19 vaccine reaction
Published in Journal of the European Academy of Dermatology and Venereology (01-10-2022)Get full text
Journal Article -
2
Upadacitinib in the treatment of difficult-to-treat psoriatic arthritis
Published in Journal of the European Academy of Dermatology and Venereology (17-06-2024)Get full text
Journal Article -
3
-
4
Effectiveness of etanercept biosimilar SB4 in maintaining low disease activity in patients with psoriatic arthritis switched from etanercept originator: an open-label one year study
Published in The Journal of dermatological treatment (02-10-2020)“…Background: Currently, there are no studies specifically aimed at investigating the effectiveness of etanercept biosimilar SB4 in psoriatic arthritis (PsA)…”
Get full text
Journal Article -
5
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study
Published in Journal of the European Academy of Dermatology and Venereology (26-06-2024)“…Facial (FP) and genital psoriasis (GP) significantly affect patients' quality of life. Despite the advances in treatments, limited data on efficacy and safety…”
Get full text
Journal Article -
6
Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: the experience of an outpatient dermatological clinic for psoriasis
Published in Clinical and experimental dermatology (01-03-2015)“…Summary Background The data in the literature concerning the frequency of remission of inflammatory arthritis in patients with psoriatic arthritis (PsA) are…”
Get full text
Journal Article -
7
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
Published in Cochrane database of systematic reviews (18-10-2006)“…Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (AIIRA) are considered to be equally effective for patients with…”
Get more information
Journal Article -
8
Immunologic Biomarkers for Clinical and Therapeutic Management of Psoriasis
Published in Mediators of Inflammation (01-01-2014)“…Background. The therapeutic management of psoriasis includes conventional treatments as well as the new generation of highly effective TNF-α inhibitors…”
Get full text
Journal Article -
9
Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection
Published in British journal of dermatology (1951) (01-06-2010)Get full text
Journal Article -
10
The diagnosis of early psoriatic arthritis in an outpatient dermatological centre for psoriasis
Published in Journal of the European Academy of Dermatology and Venereology (01-05-2012)“…Background Most of the data currently available on early psoriatic arthritis (EPsA) derive from studies performed in rheumatological settings. However, in…”
Get full text
Journal Article -
11
hMena: altered expression in psoriatic skin
Published in Archives of Dermatological Research (01-12-2013)“…Psoriasis is a chronic inflammatory skin disease, characterized by an enhanced proliferation and a deregulated differentiation of keratinocytes. hMena is an…”
Get full text
Journal Article -
12
Simultaneous occurrence of linear scleroderma and homolateral segmental vitiligo
Published in Journal of the European Academy of Dermatology and Venereology (01-01-2006)“…Localized scleroderma and vitiligo only rarely have been reported to occur simultaneously. Here we report a case of a 21 year old man affected with both linear…”
Get full text
Journal Article -
13
High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer
Published in Journal of biological regulators and homeostatic agents (01-04-2011)“…The early diagnosis and treatment of individuals harboring M. tuberculosis is key to ensuring the effectiveness of health programs aimed at the elimination of…”
Get more information
Journal Article -
14
Clinical outcome measures of psoriasis
Published in Reumatismo (01-01-2007)“…Several tools have been introduced in clinical trials to quantify the severity and the response to a given therapeutic regimen of both psoriasis and psoriatic…”
Get full text
Journal Article -
15
Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis
Published in Experimental dermatology (01-05-2006)“…: We investigated the relationship between eight polymorphisms in the gene encoding for vascular endothelial growth factor (VEGF) (−1540C > A, −1512Ins18,…”
Get full text
Journal Article -
16
Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity
Published in British journal of dermatology (1951) (01-04-1998)“…Few and contrasting data are available in the literature concerning the levels of various cytokines in blister fluid (BF) and in the serum of patients affected…”
Get full text
Journal Article Conference Proceeding -
17
Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids
Published in Clinical and experimental dermatology (01-11-2005)“…Summary Subcorneal pustular dermatosis (SCPD) is an uncommon disorder, characterized by a chronic relapsing vesiculopustular eruption, mainly involving the…”
Get full text
Journal Article -
18
Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy
Published in Dermatology online journal (15-05-2010)“…The occurrence of sarcoidosis during anti-TNF-alpha therapy has occasionally been published. We report the case of a psoriasis patient who developed pulmonary…”
Get full text
Journal Article -
19
Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma
Published in Case reports in rheumatology (01-01-2012)“…Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). The drug, alone or in combination…”
Get full text
Journal Article -
20
Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients--relationships with disease severity
Published in Clinical and experimental dermatology (01-09-1994)“…Tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and granulocyte monocyte-colony stimulating factor (GM-CSF) were measured in serum and involved…”
Get more information
Journal Article